1. Home
  2. NCPL vs CHEK Comparison

NCPL vs CHEK Comparison

Compare NCPL & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCPL
  • CHEK
  • Stock Information
  • Founded
  • NCPL 1984
  • CHEK 2004
  • Country
  • NCPL United States
  • CHEK Israel
  • Employees
  • NCPL N/A
  • CHEK N/A
  • Industry
  • NCPL Investment Managers
  • CHEK Medical Electronics
  • Sector
  • NCPL Finance
  • CHEK Health Care
  • Exchange
  • NCPL Nasdaq
  • CHEK Nasdaq
  • Market Cap
  • NCPL 3.4M
  • CHEK 4.0M
  • IPO Year
  • NCPL N/A
  • CHEK 2015
  • Fundamental
  • Price
  • NCPL $1.89
  • CHEK $0.67
  • Analyst Decision
  • NCPL
  • CHEK
  • Analyst Count
  • NCPL 0
  • CHEK 0
  • Target Price
  • NCPL N/A
  • CHEK N/A
  • AVG Volume (30 Days)
  • NCPL 55.1K
  • CHEK 27.9K
  • Earning Date
  • NCPL 03-17-2025
  • CHEK 05-14-2025
  • Dividend Yield
  • NCPL N/A
  • CHEK N/A
  • EPS Growth
  • NCPL N/A
  • CHEK N/A
  • EPS
  • NCPL N/A
  • CHEK N/A
  • Revenue
  • NCPL $812,612.00
  • CHEK N/A
  • Revenue This Year
  • NCPL N/A
  • CHEK N/A
  • Revenue Next Year
  • NCPL $101.16
  • CHEK N/A
  • P/E Ratio
  • NCPL N/A
  • CHEK N/A
  • Revenue Growth
  • NCPL N/A
  • CHEK N/A
  • 52 Week Low
  • NCPL $1.41
  • CHEK $0.56
  • 52 Week High
  • NCPL $22.82
  • CHEK $3.04
  • Technical
  • Relative Strength Index (RSI)
  • NCPL 52.31
  • CHEK 40.14
  • Support Level
  • NCPL $1.50
  • CHEK $0.65
  • Resistance Level
  • NCPL $1.99
  • CHEK $0.73
  • Average True Range (ATR)
  • NCPL 0.13
  • CHEK 0.06
  • MACD
  • NCPL 0.03
  • CHEK -0.00
  • Stochastic Oscillator
  • NCPL 79.59
  • CHEK 25.00

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: